StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Anika Therapeutics's price to sales ratio was 1.5× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 1.0× to 4.1×, with a median of 2.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×+0.3
2025Dec 31, 20251.2×−0.6
2024Dec 31, 20241.8×−0.2
2023Dec 29, 20232.0×−0.8
2022Dec 30, 20222.8×−0.7
2021Dec 31, 20213.6×−1.5
2020Dec 31, 20205.0×−1.6
2019Dec 31, 20196.6×+2.2
2018Dec 31, 20184.4×−2.6
2017Dec 29, 20177.0×+0.2
2016Dec 30, 20166.8×+0.1
2015Dec 31, 20156.7×+0.9
2014Dec 31, 20145.8×−1.3
2013Dec 31, 20137.1×+5.1
2012Dec 31, 20122.0×−0.1
2011Dec 30, 20112.2×+0.3
2010Dec 31, 20101.9×–

More Anika Therapeutics figures

See a number that looks wrong?